- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05955703
Evaluation of the Effect of the Training Program Based on the Precede-Proceed Model on Guality Life Style
Evaluation of the Effect of the Training Program Based on the Precede-Proceed Model on Adherence to Treatment and Healthy Lifestyle Behaviors of Hemodialysis Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Yakutiye
-
Erzurum, Yakutiye, Turkey
- Ataturk University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older,
- Hemodialysis treatment for at least 6 months,
- A total score of 1 or more from the Dialysis Diet and Fluid Restriction Non-Compliance Scale,
- A score between 1 and 7 on the scale of compliance with medical treatment,
- Place, time, person orientation,
- Does not have a psychiatric illness or a problem that prevents written or verbal communication,
Exclusion Criteria:
- Diagnosed with psychiatric illness Individuals with a diagnosis of malignancy wanting to leave research
- Those who do not attend all of the trainings / do not want to continue
- Individuals whose general condition is deteriorated
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Using the experimental group as a result of the training based on PPM
The training sessions planned within the scope of PPM were applied to the patients, who were divided into groups of six according to the bed order, for 15-20 minutes for eight weeks, when the patients felt well, through training booklets and power point presentations. When the trainings started, the posters prepared were hung in the waiting room while the intervention group was undergoing hemodialysis. The person providing the care of the patient was included in each training. During the trainings, it was requested that the training booklets be with the patients and the power point presentations continued in parallel with the training booklets.
|
The training program based on the precede proceed model was applied to hemodialysis patients for 8 sessions.
Eight sessions of training were given to the experimental group within the scope of the model, a booklet was developed in line with the trainings and posters were prepared.
|
No Intervention: Using the control group as a result of the training based on PPM
After the follow-up test, training was given to the patients in the control group and a model-based training booklet was distributed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of the Effect of the Training Program based on the Precede-Proceed Model on quality of life style of Hemodialysis Patients
Time Frame: six month
|
The patients' quality of life was evaluated with the SF-12 Quality of Life scale.
The scale consists of 12 items.
There is no breakpoint.
The higher the score obtained from the scale, the higher the quality of life.
|
six month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
2. Evaluation of the Effects of the Continuation Test (follow-up test results 3 months after the post-test) and the Education Program Based on the Pre-Continuation Model on the Quality of Life of Hemodialysis Patients
Time Frame: three month
|
The patients' quality of life was evaluated with the SF-12 Quality of Life scale.
The scale consists of 12 items.
There is no breakpoint.
The higher the score obtained from the scale, the higher the quality of life.
|
three month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AYSENUR-TEZ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis Patient
-
Beijing Friendship HospitalCompletedMaintenance Hemodialysis | Older Patient
-
Abdullah GerçekCompletedHemodialysis Complication | Motivation | Patient ComplianceTurkey
-
Aydin Adnan Menderes UniversityCompletedQuality of Life | Physical Activity | Hemodialysis | PatientTurkey
-
Cooperativa Asistencia Sindicato Médico UruguayCompletedVitamin D Deficiency | Hemodialysis Patient
-
B.C. van JaarsveldRadboud University Medical Center; UMC Utrecht; Jessa Hospital; Catharina Ziekenhuis... and other collaboratorsActive, not recruitingQuality of Life | Hemodialysis | Peritoneal Dialysis | Kidney Failure, Chronic | Informal Caregivers | Renal Replacement Therapy | Patient Reported Outcome Measures | Family Caregivers | Hemodialysis, HomeNetherlands, Belgium
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
Ain Shams UniversityCompleted
-
Imperial College Healthcare NHS TrustCompletedHemodialysisUnited Kingdom
-
Lawson Health Research InstituteUnknown
Clinical Trials on ppm based training
-
Procter and GambleCompleted
-
Martin W. CaseUniversity of North CarolinaRecruitingSymptoms and Signs | Lung Injury, Acute | Neutrophilia AcuteUnited States
-
Rutgers, The State University of New JerseyCompleted
-
Umeå UniversityKarlstad UniversityRecruitingParkinson Disease | Cognitive ImpairmentSweden
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDiabetes MellitusJapan
-
Maxima Medical CenterCompletedMyocardial Infarction | Acute Coronary SyndromeNetherlands
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
Mamta ParikhNational Cancer Institute (NCI)RecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Recurrent Non-Muscle Invasive Bladder CarcinomaUnited States
-
GlaxoSmithKlineCompletedOral HygieneUnited States
-
Procter and GambleCompleted